Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of Oral Nifedipine CR 80 mg in Essential Hypertension
NCT01294215Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of nifedipine in essential hypertension, sponsored by Bayer. Primary endpoint: Diastolic Blood Pressure at 52 weeks. Started Feb 2011; status: completed.
02
Drugs
nifedipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01294215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294215.